# Arcus Biosciences (RCUS) — Analyst Forecast

RCUS · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/rcus/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 14, 2026 | JP Morgan | Initiated Coverage | Overweight | $41.00 |
| Sep 30, 2026 | Wedbush | Maintained | Outperform | $43.00 |
| Sep 16, 2026 | TD Cowen | Initiated Coverage | Buy | — |
| Sep 8, 2026 | Truist Securities | Maintained | Buy | $40.00 |
| Aug 6, 2026 | Wedbush | Maintained | Outperform | $43.00 |
| Aug 6, 2026 | Wells Fargo | Maintained | Equal-Weight | $26.00 |
| Jul 20, 2026 | HC Wainwright & Co. | Maintained | Buy | $45.00 |
| Jun 4, 2026 | LifeSci Capital | Initiated Coverage | Outperform | $46.00 |
| May 18, 2026 | Truist Securities | Initiated Coverage | Buy | $35.00 |
| May 11, 2026 | Morgan Stanley | Maintained | Equal-Weight | $22.00 |
| May 7, 2026 | Goldman Sachs | Maintained | Buy | $34.00 |
| Apr 2, 2026 | Wedbush | Maintained | Outperform | $41.00 |
| Mar 5, 2026 | Citigroup | Maintained | Buy | $45.00 |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Buy | $32.00 |
| Mar 2, 2026 | Leerink Partners | Maintained | Outperform | $49.00 |
| Feb 12, 2026 | Wells Fargo | Downgraded | Overweight → Equal-Weight | $23.00 |
| Jan 13, 2026 | Goldman Sachs | Upgraded | Neutral → Buy | $28.00 |
| Jan 8, 2026 | Morgan Stanley | Downgraded | Overweight → Equal-Weight | $20.00 |
| Dec 12, 2025 | HC Wainwright & Co. | Maintained | Buy | $32.00 |
| Nov 28, 2025 | B of A Securities | Maintained | Neutral | $26.00 |

## Frequently Asked Questions

### What is the latest analyst rating on RCUS?

On Oct 14, 2026, JP Morgan initiated coverage of Arcus Biosciences at Overweight with a price target of $41.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).